Global Peptides
Global Peptides

Peptides Comprehensive Study by Type (Custom Peptides (Standard Peptides, Quant Peptides, Cyclic Custom Peptides, Others), Catalog Peptides (Neuroscience, Cardiovascular, Diabetes, Others)), Application (Commercial, Academic Research, Therapeutics), Natural Peptides (Insulin, Endorphins, Somatropin) Players and Region - Global Market Outlook to 2024

Peptides Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Oct 2019 Edition 239 Pages 188 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Peptides Market Scope
Peptides are naturally occurring biological molecules, it found in all living organisms and play major role in biological activity. Synthesized forms of peptides are formed naturally from the transcription of a sequence of the genetic code, DNA. Peptides are found in every cell and tissue and perform a wide range of essential functions. To achieve good homeostasis it is very important to maintain the appropriate concentration of peptides. The major function of peptide is dependent on the types of amino acids involved in the chain and their sequence. Peptide medicines are effectively used to replace or mimic the functions of naturally occurring peptides or to imitate the ability of peptides to engage targets in a highly potent and selective manner. Few peptide therapies are made by using chemical processes, while rest are produced inside genetically modified cells.

The market study is being classified by Type (Custom Peptides (Standard Peptides, Quant Peptides, Cyclic Custom Peptides, Others) and Catalog Peptides (Neuroscience, Cardiovascular, Diabetes, Others)), by Application (Commercial, Academic Research and Therapeutics) and major geographies with country level break-up.

The global peptides market is highly competitive and consists of some key players. In terms of market share, few of the key players presently dominate the global market. These market players are leveraging on strategic collaborative creativities to intensification their market share and escalation their profitability. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Peptides market throughout the predicted period.

Zealand Pharma A/S (Denmark), Tocris Bioscience (England), AnaSpec, Inc. (United States), CSBio (United States), GL Biochem (Shanghai) Ltd. (China), CPC Scientific Inc. (United States), Auspep Pty Ltd. (Australia), Peptides International Inc. (United States), Applied Biological Materials (ABM) Inc. (Canada), Thermo Fisher Scientific (United States) and PolyPeptide Group (Sweden) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Enzo Life Sciences, Inc. (United States), JPT Peptide Technologies (Germany), Abcam (Cambridgeshire), Amgen Inc. (United States) and Aviva Systems Biology Corporation (United States).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Peptides market by Type, Application and Region.

On the basis of geography, the market of Peptides has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Leaders and their expansionary development strategies
In March 2019, Alexion Pharmaceuticals and Zealand Pharma announced the collaboration to discover and develop novel peptide therapies for mediated diseases. Through this collaboration, Alexion gets exclusive worldwide license, development and commercial rights within the complement pathways.
In Mar 2019, Creative Peptides announced the launch of its new pharmaceutical peptides services and with the extension of the application of peptides into a pharmaceutical research and drug development.


Market Trend
  • Development in Manufacturing Technologies of Peptides
  • High Demand of Catalog Peptides in Commercial Applications

Market Drivers
  • Growing Demand of Research and Development Protein-Based Activities
  • Increase Burden of Chronic Diseases

Opportunities
  • Advancement in Research and Development Industry
  • Growing Number of Pharmaceutical and Biotechnology Companies in Asia Pacific Regions

Restraints
  • High Cost of Manufacturing Process
  • High Contamination Issues While Peptides Synthesis and Growing Requirement of Drug Development
  • Rapid Development in Drug Production Technologies

Challenges
  • Stringent Regulations in Various Regions


Analyst View
To study the market, we approach the market from the business side. Major players in peptides are continuously investing in protein research and development sector. The top players in peptides market are enhancing their global foot print in various regions.

Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Peptides Manufacturers, Suppliers, and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Custom Peptides (Standard Peptides, Quant Peptides, Cyclic Custom Peptides, Others)
  • Catalog Peptides (Neuroscience, Cardiovascular, Diabetes, Others)
By Application
  • Commercial
  • Academic Research
  • Therapeutics
By Natural Peptides
  • Insulin
  • Endorphins
  • Somatropin

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Demand of Research and Development Protein-Based Activities
      • 3.2.2. Increase Burden of Chronic Diseases
    • 3.3. Market Challenges
      • 3.3.1. Stringent Regulations in Various Regions
    • 3.4. Market Trends
      • 3.4.1. Development in Manufacturing Technologies of Peptides
      • 3.4.2. High Demand of Catalog Peptides in Commercial Applications
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Peptides, by Type, Application, Natural Peptides and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Peptides (Value)
      • 5.2.1. Global Peptides by: Type (Value)
        • 5.2.1.1. Custom Peptides (Standard Peptides, Quant Peptides, Cyclic Custom Peptides, Others)
        • 5.2.1.2. Catalog Peptides (Neuroscience, Cardiovascular, Diabetes, Others)
      • 5.2.2. Global Peptides by: Application (Value)
        • 5.2.2.1. Commercial
        • 5.2.2.2. Academic Research
        • 5.2.2.3. Therapeutics
      • 5.2.3. Global Peptides by: Natural Peptides (Value)
        • 5.2.3.1. Insulin
        • 5.2.3.2. Endorphins
        • 5.2.3.3. Somatropin
      • 5.2.4. Global Peptides Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Peptides (Volume)
      • 5.3.1. Global Peptides by: Type (Volume)
        • 5.3.1.1. Custom Peptides (Standard Peptides, Quant Peptides, Cyclic Custom Peptides, Others)
        • 5.3.1.2. Catalog Peptides (Neuroscience, Cardiovascular, Diabetes, Others)
      • 5.3.2. Global Peptides by: Application (Volume)
        • 5.3.2.1. Commercial
        • 5.3.2.2. Academic Research
        • 5.3.2.3. Therapeutics
      • 5.3.3. Global Peptides by: Natural Peptides (Volume)
        • 5.3.3.1. Insulin
        • 5.3.3.2. Endorphins
        • 5.3.3.3. Somatropin
      • 5.3.4. Global Peptides Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Peptides (Price)
      • 5.4.1. Global Peptides by: Type (Price)
  • 6. Peptides: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Zealand Pharma A/S (Denmark)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Tocris Bioscience (England)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. AnaSpec, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. CSBio (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. GL Biochem (Shanghai) Ltd. (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. CPC Scientific Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Auspep Pty Ltd. (Australia)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Peptides International Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Applied Biological Materials (ABM) Inc. (Canada)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Thermo Fisher Scientific (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. PolyPeptide Group (Sweden)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Peptides Sale, by Type, Application, Natural Peptides and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Peptides (Value)
      • 7.2.1. Global Peptides by: Type (Value)
        • 7.2.1.1. Custom Peptides (Standard Peptides, Quant Peptides, Cyclic Custom Peptides, Others)
        • 7.2.1.2. Catalog Peptides (Neuroscience, Cardiovascular, Diabetes, Others)
      • 7.2.2. Global Peptides by: Application (Value)
        • 7.2.2.1. Commercial
        • 7.2.2.2. Academic Research
        • 7.2.2.3. Therapeutics
      • 7.2.3. Global Peptides by: Natural Peptides (Value)
        • 7.2.3.1. Insulin
        • 7.2.3.2. Endorphins
        • 7.2.3.3. Somatropin
      • 7.2.4. Global Peptides Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Peptides (Volume)
      • 7.3.1. Global Peptides by: Type (Volume)
        • 7.3.1.1. Custom Peptides (Standard Peptides, Quant Peptides, Cyclic Custom Peptides, Others)
        • 7.3.1.2. Catalog Peptides (Neuroscience, Cardiovascular, Diabetes, Others)
      • 7.3.2. Global Peptides by: Application (Volume)
        • 7.3.2.1. Commercial
        • 7.3.2.2. Academic Research
        • 7.3.2.3. Therapeutics
      • 7.3.3. Global Peptides by: Natural Peptides (Volume)
        • 7.3.3.1. Insulin
        • 7.3.3.2. Endorphins
        • 7.3.3.3. Somatropin
      • 7.3.4. Global Peptides Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Peptides (Price)
      • 7.4.1. Global Peptides by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Peptides: by Type(USD Million)
  • Table 2. Peptides Custom Peptides (Standard Peptides, Quant Peptides, Cyclic Custom Peptides, Others) , by Region USD Million (2013-2018)
  • Table 3. Peptides Catalog Peptides (Neuroscience, Cardiovascular, Diabetes, Others) , by Region USD Million (2013-2018)
  • Table 4. Peptides: by Application(USD Million)
  • Table 5. Peptides Commercial , by Region USD Million (2013-2018)
  • Table 6. Peptides Academic Research , by Region USD Million (2013-2018)
  • Table 7. Peptides Therapeutics , by Region USD Million (2013-2018)
  • Table 8. Peptides: by Natural Peptides(USD Million)
  • Table 9. Peptides Insulin , by Region USD Million (2013-2018)
  • Table 10. Peptides Endorphins , by Region USD Million (2013-2018)
  • Table 11. Peptides Somatropin , by Region USD Million (2013-2018)
  • Table 12. South America Peptides, by Country USD Million (2013-2018)
  • Table 13. South America Peptides, by Type USD Million (2013-2018)
  • Table 14. South America Peptides, by Application USD Million (2013-2018)
  • Table 15. South America Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 16. Brazil Peptides, by Type USD Million (2013-2018)
  • Table 17. Brazil Peptides, by Application USD Million (2013-2018)
  • Table 18. Brazil Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 19. Argentina Peptides, by Type USD Million (2013-2018)
  • Table 20. Argentina Peptides, by Application USD Million (2013-2018)
  • Table 21. Argentina Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 22. Rest of South America Peptides, by Type USD Million (2013-2018)
  • Table 23. Rest of South America Peptides, by Application USD Million (2013-2018)
  • Table 24. Rest of South America Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 25. Asia Pacific Peptides, by Country USD Million (2013-2018)
  • Table 26. Asia Pacific Peptides, by Type USD Million (2013-2018)
  • Table 27. Asia Pacific Peptides, by Application USD Million (2013-2018)
  • Table 28. Asia Pacific Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 29. China Peptides, by Type USD Million (2013-2018)
  • Table 30. China Peptides, by Application USD Million (2013-2018)
  • Table 31. China Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 32. Japan Peptides, by Type USD Million (2013-2018)
  • Table 33. Japan Peptides, by Application USD Million (2013-2018)
  • Table 34. Japan Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 35. India Peptides, by Type USD Million (2013-2018)
  • Table 36. India Peptides, by Application USD Million (2013-2018)
  • Table 37. India Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 38. South Korea Peptides, by Type USD Million (2013-2018)
  • Table 39. South Korea Peptides, by Application USD Million (2013-2018)
  • Table 40. South Korea Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 41. Taiwan Peptides, by Type USD Million (2013-2018)
  • Table 42. Taiwan Peptides, by Application USD Million (2013-2018)
  • Table 43. Taiwan Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 44. Australia Peptides, by Type USD Million (2013-2018)
  • Table 45. Australia Peptides, by Application USD Million (2013-2018)
  • Table 46. Australia Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 47. Rest of Asia-Pacific Peptides, by Type USD Million (2013-2018)
  • Table 48. Rest of Asia-Pacific Peptides, by Application USD Million (2013-2018)
  • Table 49. Rest of Asia-Pacific Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 50. Europe Peptides, by Country USD Million (2013-2018)
  • Table 51. Europe Peptides, by Type USD Million (2013-2018)
  • Table 52. Europe Peptides, by Application USD Million (2013-2018)
  • Table 53. Europe Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 54. Germany Peptides, by Type USD Million (2013-2018)
  • Table 55. Germany Peptides, by Application USD Million (2013-2018)
  • Table 56. Germany Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 57. France Peptides, by Type USD Million (2013-2018)
  • Table 58. France Peptides, by Application USD Million (2013-2018)
  • Table 59. France Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 60. Italy Peptides, by Type USD Million (2013-2018)
  • Table 61. Italy Peptides, by Application USD Million (2013-2018)
  • Table 62. Italy Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 63. United Kingdom Peptides, by Type USD Million (2013-2018)
  • Table 64. United Kingdom Peptides, by Application USD Million (2013-2018)
  • Table 65. United Kingdom Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 66. Netherlands Peptides, by Type USD Million (2013-2018)
  • Table 67. Netherlands Peptides, by Application USD Million (2013-2018)
  • Table 68. Netherlands Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 69. Rest of Europe Peptides, by Type USD Million (2013-2018)
  • Table 70. Rest of Europe Peptides, by Application USD Million (2013-2018)
  • Table 71. Rest of Europe Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 72. MEA Peptides, by Country USD Million (2013-2018)
  • Table 73. MEA Peptides, by Type USD Million (2013-2018)
  • Table 74. MEA Peptides, by Application USD Million (2013-2018)
  • Table 75. MEA Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 76. Middle East Peptides, by Type USD Million (2013-2018)
  • Table 77. Middle East Peptides, by Application USD Million (2013-2018)
  • Table 78. Middle East Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 79. Africa Peptides, by Type USD Million (2013-2018)
  • Table 80. Africa Peptides, by Application USD Million (2013-2018)
  • Table 81. Africa Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 82. North America Peptides, by Country USD Million (2013-2018)
  • Table 83. North America Peptides, by Type USD Million (2013-2018)
  • Table 84. North America Peptides, by Application USD Million (2013-2018)
  • Table 85. North America Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 86. United States Peptides, by Type USD Million (2013-2018)
  • Table 87. United States Peptides, by Application USD Million (2013-2018)
  • Table 88. United States Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 89. Canada Peptides, by Type USD Million (2013-2018)
  • Table 90. Canada Peptides, by Application USD Million (2013-2018)
  • Table 91. Canada Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 92. Mexico Peptides, by Type USD Million (2013-2018)
  • Table 93. Mexico Peptides, by Application USD Million (2013-2018)
  • Table 94. Mexico Peptides, by Natural Peptides USD Million (2013-2018)
  • Table 95. Peptides Sales: by Type(K Units)
  • Table 96. Peptides Sales Custom Peptides (Standard Peptides, Quant Peptides, Cyclic Custom Peptides, Others) , by Region K Units (2013-2018)
  • Table 97. Peptides Sales Catalog Peptides (Neuroscience, Cardiovascular, Diabetes, Others) , by Region K Units (2013-2018)
  • Table 98. Peptides Sales: by Application(K Units)
  • Table 99. Peptides Sales Commercial , by Region K Units (2013-2018)
  • Table 100. Peptides Sales Academic Research , by Region K Units (2013-2018)
  • Table 101. Peptides Sales Therapeutics , by Region K Units (2013-2018)
  • Table 102. Peptides Sales: by Natural Peptides(K Units)
  • Table 103. Peptides Sales Insulin , by Region K Units (2013-2018)
  • Table 104. Peptides Sales Endorphins , by Region K Units (2013-2018)
  • Table 105. Peptides Sales Somatropin , by Region K Units (2013-2018)
  • Table 106. South America Peptides Sales, by Country K Units (2013-2018)
  • Table 107. South America Peptides Sales, by Type K Units (2013-2018)
  • Table 108. South America Peptides Sales, by Application K Units (2013-2018)
  • Table 109. South America Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 110. Brazil Peptides Sales, by Type K Units (2013-2018)
  • Table 111. Brazil Peptides Sales, by Application K Units (2013-2018)
  • Table 112. Brazil Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 113. Argentina Peptides Sales, by Type K Units (2013-2018)
  • Table 114. Argentina Peptides Sales, by Application K Units (2013-2018)
  • Table 115. Argentina Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 116. Rest of South America Peptides Sales, by Type K Units (2013-2018)
  • Table 117. Rest of South America Peptides Sales, by Application K Units (2013-2018)
  • Table 118. Rest of South America Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 119. Asia Pacific Peptides Sales, by Country K Units (2013-2018)
  • Table 120. Asia Pacific Peptides Sales, by Type K Units (2013-2018)
  • Table 121. Asia Pacific Peptides Sales, by Application K Units (2013-2018)
  • Table 122. Asia Pacific Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 123. China Peptides Sales, by Type K Units (2013-2018)
  • Table 124. China Peptides Sales, by Application K Units (2013-2018)
  • Table 125. China Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 126. Japan Peptides Sales, by Type K Units (2013-2018)
  • Table 127. Japan Peptides Sales, by Application K Units (2013-2018)
  • Table 128. Japan Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 129. India Peptides Sales, by Type K Units (2013-2018)
  • Table 130. India Peptides Sales, by Application K Units (2013-2018)
  • Table 131. India Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 132. South Korea Peptides Sales, by Type K Units (2013-2018)
  • Table 133. South Korea Peptides Sales, by Application K Units (2013-2018)
  • Table 134. South Korea Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 135. Taiwan Peptides Sales, by Type K Units (2013-2018)
  • Table 136. Taiwan Peptides Sales, by Application K Units (2013-2018)
  • Table 137. Taiwan Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 138. Australia Peptides Sales, by Type K Units (2013-2018)
  • Table 139. Australia Peptides Sales, by Application K Units (2013-2018)
  • Table 140. Australia Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 141. Rest of Asia-Pacific Peptides Sales, by Type K Units (2013-2018)
  • Table 142. Rest of Asia-Pacific Peptides Sales, by Application K Units (2013-2018)
  • Table 143. Rest of Asia-Pacific Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 144. Europe Peptides Sales, by Country K Units (2013-2018)
  • Table 145. Europe Peptides Sales, by Type K Units (2013-2018)
  • Table 146. Europe Peptides Sales, by Application K Units (2013-2018)
  • Table 147. Europe Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 148. Germany Peptides Sales, by Type K Units (2013-2018)
  • Table 149. Germany Peptides Sales, by Application K Units (2013-2018)
  • Table 150. Germany Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 151. France Peptides Sales, by Type K Units (2013-2018)
  • Table 152. France Peptides Sales, by Application K Units (2013-2018)
  • Table 153. France Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 154. Italy Peptides Sales, by Type K Units (2013-2018)
  • Table 155. Italy Peptides Sales, by Application K Units (2013-2018)
  • Table 156. Italy Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 157. United Kingdom Peptides Sales, by Type K Units (2013-2018)
  • Table 158. United Kingdom Peptides Sales, by Application K Units (2013-2018)
  • Table 159. United Kingdom Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 160. Netherlands Peptides Sales, by Type K Units (2013-2018)
  • Table 161. Netherlands Peptides Sales, by Application K Units (2013-2018)
  • Table 162. Netherlands Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 163. Rest of Europe Peptides Sales, by Type K Units (2013-2018)
  • Table 164. Rest of Europe Peptides Sales, by Application K Units (2013-2018)
  • Table 165. Rest of Europe Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 166. MEA Peptides Sales, by Country K Units (2013-2018)
  • Table 167. MEA Peptides Sales, by Type K Units (2013-2018)
  • Table 168. MEA Peptides Sales, by Application K Units (2013-2018)
  • Table 169. MEA Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 170. Middle East Peptides Sales, by Type K Units (2013-2018)
  • Table 171. Middle East Peptides Sales, by Application K Units (2013-2018)
  • Table 172. Middle East Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 173. Africa Peptides Sales, by Type K Units (2013-2018)
  • Table 174. Africa Peptides Sales, by Application K Units (2013-2018)
  • Table 175. Africa Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 176. North America Peptides Sales, by Country K Units (2013-2018)
  • Table 177. North America Peptides Sales, by Type K Units (2013-2018)
  • Table 178. North America Peptides Sales, by Application K Units (2013-2018)
  • Table 179. North America Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 180. United States Peptides Sales, by Type K Units (2013-2018)
  • Table 181. United States Peptides Sales, by Application K Units (2013-2018)
  • Table 182. United States Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 183. Canada Peptides Sales, by Type K Units (2013-2018)
  • Table 184. Canada Peptides Sales, by Application K Units (2013-2018)
  • Table 185. Canada Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 186. Mexico Peptides Sales, by Type K Units (2013-2018)
  • Table 187. Mexico Peptides Sales, by Application K Units (2013-2018)
  • Table 188. Mexico Peptides Sales, by Natural Peptides K Units (2013-2018)
  • Table 189. Peptides: by Type(USD/Units)
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Peptides: by Type(USD Million)
  • Table 202. Peptides Custom Peptides (Standard Peptides, Quant Peptides, Cyclic Custom Peptides, Others) , by Region USD Million (2019-2024)
  • Table 203. Peptides Catalog Peptides (Neuroscience, Cardiovascular, Diabetes, Others) , by Region USD Million (2019-2024)
  • Table 204. Peptides: by Application(USD Million)
  • Table 205. Peptides Commercial , by Region USD Million (2019-2024)
  • Table 206. Peptides Academic Research , by Region USD Million (2019-2024)
  • Table 207. Peptides Therapeutics , by Region USD Million (2019-2024)
  • Table 208. Peptides: by Natural Peptides(USD Million)
  • Table 209. Peptides Insulin , by Region USD Million (2019-2024)
  • Table 210. Peptides Endorphins , by Region USD Million (2019-2024)
  • Table 211. Peptides Somatropin , by Region USD Million (2019-2024)
  • Table 212. South America Peptides, by Country USD Million (2019-2024)
  • Table 213. South America Peptides, by Type USD Million (2019-2024)
  • Table 214. South America Peptides, by Application USD Million (2019-2024)
  • Table 215. South America Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 216. Brazil Peptides, by Type USD Million (2019-2024)
  • Table 217. Brazil Peptides, by Application USD Million (2019-2024)
  • Table 218. Brazil Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 219. Argentina Peptides, by Type USD Million (2019-2024)
  • Table 220. Argentina Peptides, by Application USD Million (2019-2024)
  • Table 221. Argentina Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 222. Rest of South America Peptides, by Type USD Million (2019-2024)
  • Table 223. Rest of South America Peptides, by Application USD Million (2019-2024)
  • Table 224. Rest of South America Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 225. Asia Pacific Peptides, by Country USD Million (2019-2024)
  • Table 226. Asia Pacific Peptides, by Type USD Million (2019-2024)
  • Table 227. Asia Pacific Peptides, by Application USD Million (2019-2024)
  • Table 228. Asia Pacific Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 229. China Peptides, by Type USD Million (2019-2024)
  • Table 230. China Peptides, by Application USD Million (2019-2024)
  • Table 231. China Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 232. Japan Peptides, by Type USD Million (2019-2024)
  • Table 233. Japan Peptides, by Application USD Million (2019-2024)
  • Table 234. Japan Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 235. India Peptides, by Type USD Million (2019-2024)
  • Table 236. India Peptides, by Application USD Million (2019-2024)
  • Table 237. India Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 238. South Korea Peptides, by Type USD Million (2019-2024)
  • Table 239. South Korea Peptides, by Application USD Million (2019-2024)
  • Table 240. South Korea Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 241. Taiwan Peptides, by Type USD Million (2019-2024)
  • Table 242. Taiwan Peptides, by Application USD Million (2019-2024)
  • Table 243. Taiwan Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 244. Australia Peptides, by Type USD Million (2019-2024)
  • Table 245. Australia Peptides, by Application USD Million (2019-2024)
  • Table 246. Australia Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 247. Rest of Asia-Pacific Peptides, by Type USD Million (2019-2024)
  • Table 248. Rest of Asia-Pacific Peptides, by Application USD Million (2019-2024)
  • Table 249. Rest of Asia-Pacific Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 250. Europe Peptides, by Country USD Million (2019-2024)
  • Table 251. Europe Peptides, by Type USD Million (2019-2024)
  • Table 252. Europe Peptides, by Application USD Million (2019-2024)
  • Table 253. Europe Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 254. Germany Peptides, by Type USD Million (2019-2024)
  • Table 255. Germany Peptides, by Application USD Million (2019-2024)
  • Table 256. Germany Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 257. France Peptides, by Type USD Million (2019-2024)
  • Table 258. France Peptides, by Application USD Million (2019-2024)
  • Table 259. France Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 260. Italy Peptides, by Type USD Million (2019-2024)
  • Table 261. Italy Peptides, by Application USD Million (2019-2024)
  • Table 262. Italy Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 263. United Kingdom Peptides, by Type USD Million (2019-2024)
  • Table 264. United Kingdom Peptides, by Application USD Million (2019-2024)
  • Table 265. United Kingdom Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 266. Netherlands Peptides, by Type USD Million (2019-2024)
  • Table 267. Netherlands Peptides, by Application USD Million (2019-2024)
  • Table 268. Netherlands Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 269. Rest of Europe Peptides, by Type USD Million (2019-2024)
  • Table 270. Rest of Europe Peptides, by Application USD Million (2019-2024)
  • Table 271. Rest of Europe Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 272. MEA Peptides, by Country USD Million (2019-2024)
  • Table 273. MEA Peptides, by Type USD Million (2019-2024)
  • Table 274. MEA Peptides, by Application USD Million (2019-2024)
  • Table 275. MEA Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 276. Middle East Peptides, by Type USD Million (2019-2024)
  • Table 277. Middle East Peptides, by Application USD Million (2019-2024)
  • Table 278. Middle East Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 279. Africa Peptides, by Type USD Million (2019-2024)
  • Table 280. Africa Peptides, by Application USD Million (2019-2024)
  • Table 281. Africa Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 282. North America Peptides, by Country USD Million (2019-2024)
  • Table 283. North America Peptides, by Type USD Million (2019-2024)
  • Table 284. North America Peptides, by Application USD Million (2019-2024)
  • Table 285. North America Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 286. United States Peptides, by Type USD Million (2019-2024)
  • Table 287. United States Peptides, by Application USD Million (2019-2024)
  • Table 288. United States Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 289. Canada Peptides, by Type USD Million (2019-2024)
  • Table 290. Canada Peptides, by Application USD Million (2019-2024)
  • Table 291. Canada Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 292. Mexico Peptides, by Type USD Million (2019-2024)
  • Table 293. Mexico Peptides, by Application USD Million (2019-2024)
  • Table 294. Mexico Peptides, by Natural Peptides USD Million (2019-2024)
  • Table 295. Peptides Sales: by Type(K Units)
  • Table 296. Peptides Sales Custom Peptides (Standard Peptides, Quant Peptides, Cyclic Custom Peptides, Others) , by Region K Units (2019-2024)
  • Table 297. Peptides Sales Catalog Peptides (Neuroscience, Cardiovascular, Diabetes, Others) , by Region K Units (2019-2024)
  • Table 298. Peptides Sales: by Application(K Units)
  • Table 299. Peptides Sales Commercial , by Region K Units (2019-2024)
  • Table 300. Peptides Sales Academic Research , by Region K Units (2019-2024)
  • Table 301. Peptides Sales Therapeutics , by Region K Units (2019-2024)
  • Table 302. Peptides Sales: by Natural Peptides(K Units)
  • Table 303. Peptides Sales Insulin , by Region K Units (2019-2024)
  • Table 304. Peptides Sales Endorphins , by Region K Units (2019-2024)
  • Table 305. Peptides Sales Somatropin , by Region K Units (2019-2024)
  • Table 306. South America Peptides Sales, by Country K Units (2019-2024)
  • Table 307. South America Peptides Sales, by Type K Units (2019-2024)
  • Table 308. South America Peptides Sales, by Application K Units (2019-2024)
  • Table 309. South America Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 310. Brazil Peptides Sales, by Type K Units (2019-2024)
  • Table 311. Brazil Peptides Sales, by Application K Units (2019-2024)
  • Table 312. Brazil Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 313. Argentina Peptides Sales, by Type K Units (2019-2024)
  • Table 314. Argentina Peptides Sales, by Application K Units (2019-2024)
  • Table 315. Argentina Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 316. Rest of South America Peptides Sales, by Type K Units (2019-2024)
  • Table 317. Rest of South America Peptides Sales, by Application K Units (2019-2024)
  • Table 318. Rest of South America Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 319. Asia Pacific Peptides Sales, by Country K Units (2019-2024)
  • Table 320. Asia Pacific Peptides Sales, by Type K Units (2019-2024)
  • Table 321. Asia Pacific Peptides Sales, by Application K Units (2019-2024)
  • Table 322. Asia Pacific Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 323. China Peptides Sales, by Type K Units (2019-2024)
  • Table 324. China Peptides Sales, by Application K Units (2019-2024)
  • Table 325. China Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 326. Japan Peptides Sales, by Type K Units (2019-2024)
  • Table 327. Japan Peptides Sales, by Application K Units (2019-2024)
  • Table 328. Japan Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 329. India Peptides Sales, by Type K Units (2019-2024)
  • Table 330. India Peptides Sales, by Application K Units (2019-2024)
  • Table 331. India Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 332. South Korea Peptides Sales, by Type K Units (2019-2024)
  • Table 333. South Korea Peptides Sales, by Application K Units (2019-2024)
  • Table 334. South Korea Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 335. Taiwan Peptides Sales, by Type K Units (2019-2024)
  • Table 336. Taiwan Peptides Sales, by Application K Units (2019-2024)
  • Table 337. Taiwan Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 338. Australia Peptides Sales, by Type K Units (2019-2024)
  • Table 339. Australia Peptides Sales, by Application K Units (2019-2024)
  • Table 340. Australia Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 341. Rest of Asia-Pacific Peptides Sales, by Type K Units (2019-2024)
  • Table 342. Rest of Asia-Pacific Peptides Sales, by Application K Units (2019-2024)
  • Table 343. Rest of Asia-Pacific Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 344. Europe Peptides Sales, by Country K Units (2019-2024)
  • Table 345. Europe Peptides Sales, by Type K Units (2019-2024)
  • Table 346. Europe Peptides Sales, by Application K Units (2019-2024)
  • Table 347. Europe Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 348. Germany Peptides Sales, by Type K Units (2019-2024)
  • Table 349. Germany Peptides Sales, by Application K Units (2019-2024)
  • Table 350. Germany Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 351. France Peptides Sales, by Type K Units (2019-2024)
  • Table 352. France Peptides Sales, by Application K Units (2019-2024)
  • Table 353. France Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 354. Italy Peptides Sales, by Type K Units (2019-2024)
  • Table 355. Italy Peptides Sales, by Application K Units (2019-2024)
  • Table 356. Italy Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 357. United Kingdom Peptides Sales, by Type K Units (2019-2024)
  • Table 358. United Kingdom Peptides Sales, by Application K Units (2019-2024)
  • Table 359. United Kingdom Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 360. Netherlands Peptides Sales, by Type K Units (2019-2024)
  • Table 361. Netherlands Peptides Sales, by Application K Units (2019-2024)
  • Table 362. Netherlands Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 363. Rest of Europe Peptides Sales, by Type K Units (2019-2024)
  • Table 364. Rest of Europe Peptides Sales, by Application K Units (2019-2024)
  • Table 365. Rest of Europe Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 366. MEA Peptides Sales, by Country K Units (2019-2024)
  • Table 367. MEA Peptides Sales, by Type K Units (2019-2024)
  • Table 368. MEA Peptides Sales, by Application K Units (2019-2024)
  • Table 369. MEA Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 370. Middle East Peptides Sales, by Type K Units (2019-2024)
  • Table 371. Middle East Peptides Sales, by Application K Units (2019-2024)
  • Table 372. Middle East Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 373. Africa Peptides Sales, by Type K Units (2019-2024)
  • Table 374. Africa Peptides Sales, by Application K Units (2019-2024)
  • Table 375. Africa Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 376. North America Peptides Sales, by Country K Units (2019-2024)
  • Table 377. North America Peptides Sales, by Type K Units (2019-2024)
  • Table 378. North America Peptides Sales, by Application K Units (2019-2024)
  • Table 379. North America Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 380. United States Peptides Sales, by Type K Units (2019-2024)
  • Table 381. United States Peptides Sales, by Application K Units (2019-2024)
  • Table 382. United States Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 383. Canada Peptides Sales, by Type K Units (2019-2024)
  • Table 384. Canada Peptides Sales, by Application K Units (2019-2024)
  • Table 385. Canada Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 386. Mexico Peptides Sales, by Type K Units (2019-2024)
  • Table 387. Mexico Peptides Sales, by Application K Units (2019-2024)
  • Table 388. Mexico Peptides Sales, by Natural Peptides K Units (2019-2024)
  • Table 389. Peptides: by Type(USD/Units)
  • Table 390. Research Programs/Design for This Report
  • Table 391. Key Data Information from Secondary Sources
  • Table 392. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Peptides: by Type USD Million (2013-2018)
  • Figure 5. Global Peptides: by Application USD Million (2013-2018)
  • Figure 6. Global Peptides: by Natural Peptides USD Million (2013-2018)
  • Figure 7. South America Peptides Share (%), by Country
  • Figure 8. Asia Pacific Peptides Share (%), by Country
  • Figure 9. Europe Peptides Share (%), by Country
  • Figure 10. MEA Peptides Share (%), by Country
  • Figure 11. North America Peptides Share (%), by Country
  • Figure 12. Global Peptides: by Type K Units (2013-2018)
  • Figure 13. Global Peptides: by Application K Units (2013-2018)
  • Figure 14. Global Peptides: by Natural Peptides K Units (2013-2018)
  • Figure 15. South America Peptides Share (%), by Country
  • Figure 16. Asia Pacific Peptides Share (%), by Country
  • Figure 17. Europe Peptides Share (%), by Country
  • Figure 18. MEA Peptides Share (%), by Country
  • Figure 19. North America Peptides Share (%), by Country
  • Figure 20. Global Peptides: by Type USD/Units (2013-2018)
  • Figure 21. Global Peptides share by Players 2018 (%)
  • Figure 22. Global Peptides share by Players (Top 3) 2018(%)
  • Figure 23. Global Peptides share by Players (Top 5) 2018(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Zealand Pharma A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 26. Zealand Pharma A/S (Denmark) Revenue: by Geography 2018
  • Figure 27. Tocris Bioscience (England) Revenue, Net Income and Gross profit
  • Figure 28. Tocris Bioscience (England) Revenue: by Geography 2018
  • Figure 29. AnaSpec, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. AnaSpec, Inc. (United States) Revenue: by Geography 2018
  • Figure 31. CSBio (United States) Revenue, Net Income and Gross profit
  • Figure 32. CSBio (United States) Revenue: by Geography 2018
  • Figure 33. GL Biochem (Shanghai) Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 34. GL Biochem (Shanghai) Ltd. (China) Revenue: by Geography 2018
  • Figure 35. CPC Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. CPC Scientific Inc. (United States) Revenue: by Geography 2018
  • Figure 37. Auspep Pty Ltd. (Australia) Revenue, Net Income and Gross profit
  • Figure 38. Auspep Pty Ltd. (Australia) Revenue: by Geography 2018
  • Figure 39. Peptides International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Peptides International Inc. (United States) Revenue: by Geography 2018
  • Figure 41. Applied Biological Materials (ABM) Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 42. Applied Biological Materials (ABM) Inc. (Canada) Revenue: by Geography 2018
  • Figure 43. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 44. Thermo Fisher Scientific (United States) Revenue: by Geography 2018
  • Figure 45. PolyPeptide Group (Sweden) Revenue, Net Income and Gross profit
  • Figure 46. PolyPeptide Group (Sweden) Revenue: by Geography 2018
  • Figure 47. Global Peptides: by Type USD Million (2019-2024)
  • Figure 48. Global Peptides: by Application USD Million (2019-2024)
  • Figure 49. Global Peptides: by Natural Peptides USD Million (2019-2024)
  • Figure 50. South America Peptides Share (%), by Country
  • Figure 51. Asia Pacific Peptides Share (%), by Country
  • Figure 52. Europe Peptides Share (%), by Country
  • Figure 53. MEA Peptides Share (%), by Country
  • Figure 54. North America Peptides Share (%), by Country
  • Figure 55. Global Peptides: by Type K Units (2019-2024)
  • Figure 56. Global Peptides: by Application K Units (2019-2024)
  • Figure 57. Global Peptides: by Natural Peptides K Units (2019-2024)
  • Figure 58. South America Peptides Share (%), by Country
  • Figure 59. Asia Pacific Peptides Share (%), by Country
  • Figure 60. Europe Peptides Share (%), by Country
  • Figure 61. MEA Peptides Share (%), by Country
  • Figure 62. North America Peptides Share (%), by Country
  • Figure 63. Global Peptides: by Type USD/Units (2019-2024)
Some of the key companies/manufacturers profiled in the report
  • Zealand Pharma A/S (Denmark)
  • Tocris Bioscience (England)
  • AnaSpec, Inc. (United States)
  • CSBio (United States)
  • GL Biochem (Shanghai) Ltd. (China)
  • CPC Scientific Inc. (United States)
  • Auspep Pty Ltd. (Australia)
  • Peptides International Inc. (United States)
  • Applied Biological Materials (ABM) Inc. (Canada)
  • Thermo Fisher Scientific (United States)
  • PolyPeptide Group (Sweden)
Additional players considered in the study are as follows:
Enzo Life Sciences, Inc. (United States) , JPT Peptide Technologies (Germany) , Abcam (Cambridgeshire) , Amgen Inc. (United States) , Aviva Systems Biology Corporation (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation